M&A Corner
Burcon NutraScience to Acquire Merit Business07 Mar 2023
Burcon NutraScience (BU:CA) to submit a formal proposal to acquire the business of Merit Functional Foods. Merit has been placed in receivership... Continue Reading
|
Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packagin07 Mar 2023
Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces that it has completed the acquisition... Continue Reading
|
Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing Capabilities07 Mar 2023
Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisitions of Click Chemistry Tools, a... Continue Reading
|
Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.07 Mar 2023
Indivior PLC (LSE: INDV) (“Indivior” or the “Company”) today announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc.... Continue Reading
|
JATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SEC07 Mar 2023
JATT Acquisition Corp (NYSE: “JATT”), the publicly traded special purpose acquisition company (“SPAC”), has today announced that the U.S. Securities... Continue Reading
|
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics07 Mar 2023
Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that its stockholders have voted to approve all... Continue Reading
|
Ipsen Completes Acquisition of Albireo, Expanding the Scope of Its Rare Disease Portfolio07 Mar 2023
Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio Bringing medicines to patients with rare liver disease, a growth opportunity for Ipsen Lead asset... Continue Reading
|
Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focused on Clinical Oncology07 Mar 2023
-Combined company to be named Flamingo Therapeutics, focused on advancing Flamingo’s asset danvatirsen in a Phase II trial PEMDA-HN in... Continue Reading
|
Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, Llc07 Mar 2023
Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical device and technology company that delivers training and a full... Continue Reading
|
Fertility Company Kindbody Scores $100M. The Funds Will be Used to Open New Clinics in the U.S.07 Mar 2023
Hybrid fertility and reproductive care company Kindbody scored a whopping $100 million from life sciences investment firm Perceptive Advisors, bringing... Continue Reading
|